For Immediate Release 19 October 2011Asterand plc

(“Asterand” or the “Company”)

Board Changes

The Company wishes to announce that Jonathan Fleming, a Non Executive Director, has resigned from the
Board with immediate effect.
Jack Davis, the Chairman and Interim CEO, said: “The Board would like to thank Jonathan for his contribution over the last few years and we wish him well for the future.”
Contacts:

Asterand plc

Jack Davis, Chairman and Interim Chief Executive Officer Tel: + 44 (0) 1763 211 600 / + 1 (313) 263-0960
Alan Fishman, Interim Chief Financial Officer As above

Buchanan Communications

Lisa Baderoon / Mark Court / Isabel Podda Tel: +44 (0) 20 7466 5000

Daniel Stewart & Company plc

Antony Legge Tel: +44 (0) 20 7776 6550
Martin Lampshire

About Asterand

Asterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.